This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits

Stocks in this article: ^GSPC NVS GSK LLY AGN VRX FB

NEW YORK (TheStreet) -- Each day we see thousands of links shared on StockTwits. The diversity is incredible, with links to articles, blog posts, charts and videos. We combed through the StockTwits stream today and found these five stories that you have to see. 

1. The American public still isn't interested in the stock market, though the S&P 500 is up roughly 116% since 2009. Take a look at this link:

Great story by @ben_rooney on how 73% of Americans still don't want to invest in stocks $SPX $SPY via @cnnmoneyinvest -- Ryan Detrick (@RyanDetrick) Apr. 22 at 10:23 AM

2. Goldman Sachs released a note about M&A activity in the biotech and pharmaceutical sectors. It essentially hints that the entire industry is entering a phase of mega deals. They might be right, too. Novartis (NVS), GlaxoSmithKline  (GSK) and Eli Lilly  (LLY) recently swapped billions in assets like a game of Uno:

Here's my graphic that summarizes the $NVS $GSK $LLY deal: -- Brad Loncar (@bradloncar) Apr. 22 at 09:06 AM

Here's the $GSK PR - so $GSK and $NVS are going to create a new consumer healthcare business too. 3-way transaction. -- Brad Loncar (@bradloncar) Apr. 22 at 01:31 AM

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs